# The Medicines (Advisory Bodies) (No. 2) Regulations 2005, Paragraph 1: Applications for, or proposals in relation to, marketing authorizations, where appropriate committee has given provisional opinion before 30th October 2005


Paragraphs 2 to 6 apply where, before 30th October 2005—
(a) the licensing authority have consulted a committee established under section 4 of the Act in relation to a marketing authorization, in accordance with paragraph 5 of Schedule 2 to the Marketing Authorization Regulations;
(b) the committee have sent notification to the applicant for, or holder of, that marketing authorization—
(i) under paragraph 6(1)(a) of Schedule 2 to the Marketing Authorization Regulations, that they may be unable to advise the licensing authority to grant or renew the authorization;
(ii) under paragraph 6(1)(b) of that Schedule, that they may be unable to grant it unless it contains provisions otherwise than in accordance with the application; or
(iii) under paragraph 6(1)(c) of that Schedule, that they may have to advise the licensing authority that the authorization ought to be revoked, varied or suspended; and
(c) the committee have not reported findings and advice to the licensing authority in relation to the application, or the proposal to suspend, revoke or vary the authorization.

---
Source: https://www.legislation.gov.uk/uksi/2005/2754/schedule/5/part/3/paragraph/1 (the official version)
Page: https://openlegislation.uk/medicines-advisory-bodies-no-2-regulations-2005/schedule-5/part-3/paragraph-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.